Life Technologies (LIFE) Acquires Navigenics, Inc.

Article Stock Quotes (2) Comments (0)

Life Technologies Corporation (NASDAQ: LIFE) announced the acquisition of Navigenics, Inc. This acquisition represents Life Technologies' first step in executing against a strategy to build out its molecular diagnostics business through internal development, partnerships and select acquisitions.

Navigenics, Inc. develops and commercializes genetics-based products and services to improve individual health. Navigenics educates and empowers individuals and their physicians by providing clinically actionable, personalized genetic insights about disease risk and medication response to catalyze behavior change and inform clinical decision-making. The company was founded by leading scientists and clinicians, and continues to advance genomic knowledge and adoption of molecular medicine through studies with leading academic centers. Among Navigenics' investors are Kleiner Perkins Caulfield and Byers, Mohr Davidow Ventures, and The Procter & Gamble Company (NYSE: PG).

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: Bausch & Lomb near deal to sell to Valeant Pharmaceuticals (VRX) - WSJ
• A.G. Lafley Returns as President/CEO of Procter & Gamble (PG)
• UPDATE: Hulu Bidding War Heats Up as Yahoo (YHOO) & Others Join Party

Create E-mail Alert Related Categories

Mergers and Acquisitions

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?